Kazia Therapeutics (KZIA) Inventory Average (2009 - 2011)
Kazia Therapeutics' (KZIA) quarterly Inventory Average came in at $476129.9 in Q4 2011, down 48.39% YoY from $922575.4 in Q4 2010, and down 38.76% on a QoQ basis from $777500.0 in Q2 2011.
Kazia Therapeutics (KZIA) Inventory Average (2009 - 2011) Analysis & Trends
Kazia Therapeutics (KZIA) has 3 years of Inventory Average data on file, last reported at $476129.9 in Q4 2011.
- Quarterly Inventory Average fell 48.39% year-over-year to $476129.9 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $476129.9 (down 48.39% YoY) and the FY2011 annual result came in at $479294.9, down 63.35% from the prior year.
- Inventory Average declined to $476129.9 in Q4 2011, from $777500.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $1.7 million in Q2 2009 to a low of $476129.9 in Q4 2011.
- A 3-year average of $978293.2 and a median of $881942.1 in 2009 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2010 — Inventory Average decreased 18.1% — and 2011, when it plunged 48.39%.
- Tracing KZIA's Inventory Average over 3 years: stood at $1.1 million in 2009, then declined by 18.1% to $922575.4 in 2010, then sank by 48.39% to $476129.9 in 2011.
- The last three Inventory Average figures came in at $476129.9 (Q4 2011), $777500.0 (Q2 2011), and $922575.4 (Q4 2010), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 476,129.91 |
| Jun 30, 2011 | 777,500.00 |
| Dec 31, 2010 | 922,575.38 |
| Jun 30, 2010 | 1.23 Mn |
| Dec 31, 2009 | 1.13 Mn |
| Nov 26, 2009 | 704,064.86 |
| Aug 25, 2009 | 841,308.78 |
| Jun 30, 2009 | 1.75 Mn |